Success Stories: EB-1A Approved for Consultant Senior Scientist in New Jersey in the Field of Pharmacology

Client’s Testimonial:

 

That's great news ! Thank you for your wonderful work. I will definitely recommend you guys to friends and family.

 


On December 29th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Consultant Senior Scientist in the Field of Pharmacology (Approval Notice)


General Field: Pharmacology

Position at the Time of Case Filing: Consultant Senior Scientist

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: December 29th, 2014

Processing Time: 26 Days (13 Days After Requesting Premium Processing)

 


Case Summary:

A consultant scientist from India who worked in pharmacology was our client in this case. His specialized research had focused on modeling metastatic behavior in cancer. His body of work comprised 4 peer-reviewed scientific articles and numerous presentations at national and international conferences; by the time we filed his case, his research had received no fewer than 342 citations from independent and leading researchers at prestigious institutions and organizations around the world, a strong indication of the major significance of his work. He has also performed peer-review service for 6 distinctive, internationally-circulated journals, reviewing at least 16 manuscripts. An independent recommender attested to our client’s superior expertise: “[Client] employed innovative models and methods to test novel chemotherapeutic drugs in order to explore uptake and delivery for brain metastases from breast cancer. The study was the first to report on the heterogeneity of drug distribution in brain tumors, the first to document the functional role of BTB and how it limits drug efficacy to brain tumors, and also managed to dispel the misunderstanding about the correlation of size to drug delivery in brain tumors.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of pharmacology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in twenty-six days.